Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
In a double-blind, placebo-controlled Phase IIIb safety trial in 3,070 patients, Cycloset met the primary and secondary endpoints of time to first all-cause SAE and time to first cardiovascular SAE. T...